ADAM12 and nonpapillary renal cell carcinoma: Further analysis of the clinical data of ccRCC patients showed that ADAM12 expression was correlated with the tumor grade, T stage, M stage, and N stage of ccRCC patients, and high ADAM12 expression was found to be an independent factor associated with shorter survival in univariate and multivariate analyses.